You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 205 No. 12, September 16, 1968 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Meningeal Leukemia

Two Simple Methods for Rapid Detection of Malignant Cells in Spinal Fluid

Roland T. Skeel, MD; Ronald A. Yankee, MD; Edward S. Henderson, MD

JAMA. 1968;205(12):863-865.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The syndrome of meningeal leukemia is one of the major complications of acute leukemia.1,2 The manifestations of the clinical syndrome include headache, nausea, vomiting, eye signs, cranial nerve palsies, and lethargy, and may be associated with increased intracranial pressure. The observation that cerebrospinal fluid (CSF) pleocytosis is almost always associated with the clinical syndrome has shifted the emphasis in the criteria for diagnosis from dependence on clinical signs and symptoms to a greater reliance on laboratory findings.3,4 More recent studies further demonstrate that the CSF pleocytosis may precede the symptoms. In the review of cases reported by Nies et al,3 the diagnosis of meningeal leukemia was said to be established by the presence of ten or more mononuclear cells per cubic millimeter in the spinal fluid. Judged by this criterion, of 38 cases of meningeal leukemia, 14 had no presenting signs or symptoms at the time of . . . [Full Text PDF of this Article]


Author Affiliations

From the National Cancer Institute, Bethesda, Md.


Footnotes

Reprint requests to Room 2B51, Bldg 10, National Cancer Institute, National Institutes of Health, Bethesda, Md 20014 (Dr. Skeel).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1968 American Medical Association. All Rights Reserved.